YI-PING WEN: Open Payments
NPI 1093947616 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$302 in 14 payments from 9 companies in 2025. Trend: 2023 $4,429 · 2024 $572 · 2025 $302
Food & beverage: $302
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 3 | $62 |
| Genentech USA, Inc. | 2 | $46 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| AstraZeneca Pharmaceuticals LP | 2 | $41 |
| Janssen Biotech, Inc. | 1 | $27 |
| Daiichi Sankyo Inc. | 1 | $25 |
| ADC THERAPEUTICS AMERICA, INC. | 1 | $23 |
| Eisai Inc. | 1 | $18 |
| Lilly USA, LLC | 1 | $16 |
Products named: VENCLEXTA, Tazverik, CALQUENCE, Polivy, DARZALEX, Vanflyta, ZYNLONTA, Lenvima.
Industry payments across CA — which companies pay providers there.
